Effectiveness and safety of thrombolytics for the treatment of ischemic stroke: a rapid review
Brener S
Record ID 32014001030
English
Authors' recommendations:
Mortality:
Based on moderate quality of evidence, there was no difference in mortality among patients who received
a recombinant tissue plasminogen (rt-Pa) activator as the thrombolytic agent compared to the control
group.
Dependency:
Based on moderate quality of evidence, there was a decrease in dependency among patients who received
a thrombolytic agent compared to control group.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/eds/rapid-reviews/stroke-effectiveness-of-thrombolytics-130114-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Stroke
- Brain Ischemia
- Fibrinolytic Agents
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.